コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 activating the nuclear receptor PPAR-alpha (peroxisome proliferator-activated receptor alpha).
2 the anti-inflammatory effect is mediated by peroxisome proliferator activated receptor-alpha.
3 on was associated with reduced activation of peroxisome proliferator-activated receptor alpha.
4 mechanism that involves the nuclear receptor peroxisome proliferator-activated receptor alpha.
5 atty acid in tissues, is a weak activator of peroxisome proliferator-activated receptor alpha.
6 bezafibrate, a hypolipidemic agonist of the peroxisome proliferator-activated receptor alpha.
7 xpression of their common regulatory factor, peroxisome proliferator-activated receptor alpha.
8 C and PECPC isomers are potent activators of peroxisome proliferator-activated receptor alpha.
9 y CaMKIIdelta deletion or inhibition, as was peroxisome proliferator-activated receptor alpha.
10 od intake by activating the nuclear receptor peroxisome proliferator-activated receptor-alpha.
11 FD providing ligands to liver X receptor and peroxisome proliferator-activated receptor-alpha.
12 ith a rate-dependent lipolytic activation of peroxisome proliferator-activated receptor-alpha.
16 ransferase 1, and their transcription factor peroxisome proliferator-activated receptor alpha, accoun
17 reliance on palmitate oxidation and blunted peroxisome proliferator--activated receptor-alpha activa
18 6,n-3, however, generates 20:5,n-3, a strong peroxisome proliferator-activated receptor alpha activat
19 activated protein kinase phosphorylation and peroxisome proliferator-activated receptor alpha activat
20 The peroxisome proliferator-activated receptor-alpha activat
21 te, in supporting endogenous TG dynamics and peroxisome proliferator-activated receptor-alpha activat
22 ecular analysis unraveled that inhibition of peroxisome proliferator-activated receptor alpha activit
23 Topical treatment with three different peroxisome proliferator activated receptor-alpha agonist
24 The anti-inflammatory properties of peroxisome proliferator activated receptor-alpha agonist
25 The reduction in inflammation by these peroxisome proliferator activated receptor-alpha agonist
26 mmunohistochemistry to determine whether the peroxisome proliferator activated receptor-alpha agonist
27 e studies demonstrate that topically applied peroxisome proliferator activated receptor-alpha agonist
28 determined the anti-inflammatory effects of peroxisome proliferator activated receptor-alpha agonist
29 Furthermore, peroxisome proliferator-activated receptor alpha agonist
30 adenoviral transduction or treatment with a peroxisome proliferator-activated receptor alpha agonist
31 oE-deficient mice with ciprofibrate or other peroxisome proliferator-activated receptor alpha agonist
32 rast to its free-acid counterpart, acts as a peroxisome proliferator-activated receptor alpha agonist
33 cannabinoid oxygenation in the generation of peroxisome proliferator-activated receptor alpha agonist
34 a rationale for the further investigation of peroxisome proliferator-activated receptor-alpha agonist
35 ellular 4-HNE accumulation by bezafibrate, a peroxisome proliferator-activated receptor-alpha agonist
36 5alpha-reductase inhibitor dutasteride, the peroxisome proliferator-activated receptor-alpha agonist
37 hormones (miR141, miR107 and miR200c through peroxisome proliferator-activated receptor alpha and ext
38 e to HFD-induced decreases in adipose tissue peroxisome proliferator-activated receptor alpha and ind
39 nes decreased by up to 50% (P<0.05), whereas peroxisome proliferator-activated receptor alpha and its
40 , despite having a lower expression level of peroxisome proliferator-activated receptor alpha and its
41 interacts with the hepatic nuclear receptors peroxisome proliferator-activated receptor alpha and liv
42 is required for LPS-mediated suppression of peroxisome proliferator-activated receptor alpha and PGC
43 ress, insulin sensitivity, and expression of peroxisome proliferator-activated receptor alpha and pro
44 ta and removed nuclear repressors, including peroxisome proliferator-activated receptor alpha and ret
45 addition to other nuclear receptors, such as peroxisome proliferator-activated receptor alpha and ret
46 that pressure overload induced decreases in peroxisome proliferator-activated receptor alpha and unc
47 activated receptor-gamma coactivator-1alpha, peroxisome proliferator-activated receptor-alpha and est
49 lic processes, e.g., the anti-IL-12 molecule peroxisome proliferator-activated receptor-alpha and thy
50 gulation of nhr-49 (an ortholog of the human peroxisome proliferator-activated receptor-alpha), and a
51 (endocannabinoids), lipid-amide agonists of peroxisome proliferator-activated receptor-alpha, and pr
53 r-activated receptor alpha, as inhibition of peroxisome proliferator-activated receptor alpha blocked
55 Peroxisome proliferator-activated receptor alpha, coacti
56 Highly unsaturated fatty acid activation of peroxisome proliferator-activated receptor alpha combine
57 sepsis and to identify the mechanism whereby peroxisome proliferator-activated receptor-alpha confers
58 ssion of multiple metabolic genes, including peroxisome proliferator-activated receptor-alpha (decrea
59 tors including retinoid X receptor-alpha and peroxisome proliferator-activated receptor-alpha, -delta
60 and clinical data with GFT505, a novel dual peroxisome proliferator-activated receptor alpha/delta (
61 sferase (SCOT; encoded by Oxct1), as well as peroxisome proliferator-activated receptor alpha-depende
62 e-dependently regulated LPCAT3 in liver in a peroxisome proliferator-activated receptor alpha-depende
63 ry compound that was recently shown to exert peroxisome proliferator-activated receptor-alpha-depende
64 educes fatty acid oxidation and prevents the peroxisome proliferator-activated receptor alpha down-re
65 metabolism, in which EPA, with a more potent peroxisome proliferator-activated receptor-alpha effect,
66 the activation of several factors, including peroxisome proliferator-activated receptor alpha, estrog
67 the JNK pathway in cardiomyocytes inhibited peroxisome proliferator-activated receptor alpha express
68 Peroxisome proliferator-activated receptor-alpha express
69 ant to survival in sepsis than hematopoietic peroxisome proliferator-activated receptor-alpha express
70 ted protein kinase-alpha, and phosphorylated peroxisome proliferator-activated receptor-alpha express
71 Expression of the PLIN5 gene is regulated by peroxisome proliferator-activated receptor-alpha, fastin
72 e biphenyl system of the previously reported peroxisome proliferator-activated receptor alpha/gamma (
73 ssion (CCAAT/enhancer binding protein alpha; peroxisome proliferator-activated receptor alpha/gamma)
74 strated that Cn directly activates the mouse peroxisome proliferator-activated receptor alpha gene pr
75 ient to confer Cn-mediated activation of the peroxisome proliferator-activated receptor alpha gene.
76 The stress-dependent effects on RCT rate and peroxisome proliferator-activated receptor-alpha gene ex
77 id, a free fatty acid that does not activate peroxisome proliferator activated receptor-alpha, had no
78 ificantly increased expression of PPARalpha (peroxisome proliferator-activated receptor alpha), IGFBP
79 n receptors, and decreased anti-inflammatory peroxisome proliferator-activated receptor alpha in the
80 increased antiinflammatory proteins A20 and peroxisome proliferator-activated receptor-alpha in huma
82 the I/R injury and prevented upregulation of peroxisome proliferator-activated receptor-alpha in Tg-d
83 ,9- and 11,12-EETs activated human and mouse peroxisome proliferator-activated receptor-alpha in tran
84 al target of the nuclear receptor PPARalpha (peroxisome proliferator-activated receptor alpha) in bot
85 red, the intestinal mRNA expression level of peroxisome proliferator-activated receptor-alpha increas
86 ATP-binding cassette transporters A1 and C6, peroxisome proliferator activated receptor alpha, interl
87 also observed, and we provide evidence that peroxisome proliferator-activated receptor alpha is cons
89 ministration of fenofibrate, this ligand for peroxisome proliferator-activated receptor-alpha is pote
91 R heterodimer partners, liver X receptor and peroxisome proliferator-activated receptor-alpha, key in
92 ich fail to absorb dietary fat, increased in peroxisome proliferator activated receptor alpha knockou
93 This diurnal regulation is attenuated in peroxisome proliferator-activated receptor alpha knockou
94 radical adduct formation was not affected in peroxisome proliferator-activated receptor alpha knockou
96 tructure of a ternary complex containing the peroxisome proliferator-activated receptor-alpha ligand-
97 g delivery of free fatty acid substrates and peroxisome proliferator-activated receptor-alpha ligands
98 ver receptor X as transcriptionally inactive peroxisome proliferator-activated receptor alpha/liver r
99 These results suggest that altered peroxisome proliferator-activated receptor-alpha-mediate
100 tetradecanoylphorbol-13-acetate treatment in peroxisome proliferator activated receptor-alpha-/- mice
101 IF1dPA mice had equally suppressed levels of peroxisome proliferator-activated receptor alpha mRNA af
103 nsporter 4, pyruvate dehydrogenase kinase 4, peroxisome proliferator-activated receptor alpha, muscle
104 of the fatty acid-activated nuclear receptor peroxisome proliferator-activated receptor-alpha (myosin
105 in CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor alpha, normal
106 ntly coactivate hepatic nuclear factor 4 and peroxisome proliferator-activated receptor alpha, nuclea
109 ators that include the endogenous agonist of peroxisome proliferator-activated receptor-alpha, palmit
110 e effects are mediated through activation of peroxisome proliferator-activated receptor alpha (PPAR a
111 e retinoid X receptor alpha (RXR alpha) plus peroxisome proliferator-activated receptor alpha (PPAR a
113 assays, oxidized EPA potently activated the peroxisome proliferator-activated receptor alpha (PPAR a
114 in liver are transcriptionally regulated by peroxisome proliferator-activated receptor alpha (PPAR a
115 of the retinoid X receptor alpha (RXR alpha)-peroxisome proliferator-activated receptor alpha (PPAR a
116 t increased the Gpat4(-/-) BAT expression of peroxisome proliferator-activated receptor alpha (PPAR)
117 ation coincided with decreased expression of peroxisome proliferator-activated receptor alpha (PPAR-a
119 ain fatty acids (LCFA) for oxidation and for peroxisome proliferator-activated receptor alpha (PPAR-a
120 enous free fatty acids are known activators, peroxisome proliferator-activated receptor alpha (PPAR-a
122 receptor type 1 (CB1) or type 2 (CB2) or via peroxisome proliferator-activated receptor alpha (PPAR-a
123 sponse is that it involves activation of the peroxisome proliferator-activated receptor alpha (PPAR-a
124 Although gemfibrozil is a known activator of peroxisome proliferator-activated receptor-alpha (PPAR-a
125 inhibits inflammatory responses by engaging peroxisome proliferator-activated receptor-alpha (PPAR-a
126 ate-binding cassette transporter A1 (ABCA1), peroxisome proliferator-activated receptor-alpha (PPAR-a
127 ild-type and dominant-negative constructs of peroxisome proliferator-activated receptor-alpha (PPAR-a
128 l, a lipid-lowering drug and an activator of peroxisome proliferator-activated receptor-alpha (PPAR-a
130 c overexpression of the transcription factor peroxisome proliferator-activated receptor-alpha (PPAR-a
135 n humans, skeletal muscle is a major site of peroxisome proliferator-activated receptor-alpha (PPAR-a
137 ocyte nuclear factor-4alpha (HNF-4alpha) and peroxisome proliferators activated receptor-alpha (PPAR-
138 how that OEA binds with high affinity to the peroxisome-proliferator-activated receptor-alpha (PPAR-a
139 e glutathione-S-transferase 4-4 (Gsta4(-/-))/peroxisome proliferator activated receptor alpha (Ppara(
140 f small interfering RNA (siRNA) to knockdown peroxisome proliferator activated receptor alpha (Ppara)
141 esponsive element binding protein 1 (CREB1), peroxisome proliferator activated receptor alpha (PPARA)
142 Peroxisome proliferator--activated receptor alpha (PPARa
143 mulation, and that Jhdm2a directly regulates peroxisome proliferator-activated receptor alpha (Ppara)
144 in mouse liver: apolipoprotein B (apoB) and peroxisome proliferator-activated receptor alpha (ppara)
145 adipocytes by controlling the expression of peroxisome proliferator-activated receptor alpha (Ppara)
147 d the translation, but not transcription, of peroxisome proliferators-activated receptor-alpha (PPARa
148 The peroxisome proliferators-activated receptor-alpha (PPARa
149 However, the nuclear receptor peroxisome proliferator activated receptor alpha (PPARal
150 The peroxisome proliferator activated receptor-alpha (PPARal
151 ect of PERC on bodyweight loss, induction of peroxisome proliferator activated receptor-alpha (PPARal
152 n, Acot1 knockdown reduced the expression of peroxisome proliferator-activated receptor alpha (PPARal
153 and stabilizes the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARal
154 phenotype caused by sustained activation of peroxisome proliferator-activated receptor alpha (PPARal
155 regulation of BCRP functional expression by peroxisome proliferator-activated receptor alpha (PPARal
156 AE oleoylethanolamide, an agonist of nuclear peroxisome proliferator-activated receptor alpha (PPARal
157 almitoylethanolamide (PEA), a ligand for the peroxisome proliferator-activated receptor alpha (PPARal
158 Activation of the peroxisome proliferator-activated receptor alpha (PPARal
159 Furthermore, knockdown of peroxisome proliferator-activated receptor alpha (PPARal
160 CREBH interacts with peroxisome proliferator-activated receptor alpha (PPARal
161 ), retinoid X receptor alpha (RXRalpha) plus peroxisome proliferator-activated receptor alpha (PPARal
162 35/236) and increased the phosphorylation of peroxisome proliferator-activated receptor alpha (PPARal
163 mouse lines expressing the nuclear receptors peroxisome proliferator-activated receptor alpha (PPARal
164 ession is downstream of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARal
165 Peroxisome proliferator-activated receptor alpha (PPARal
166 igated whether Astragaloside IV can activate peroxisome proliferator-activated receptor alpha (PPARal
167 reatment, probably through the activation of peroxisome proliferator-activated receptor alpha (PPARal
168 AT6) decreases insulin action and enhances a peroxisome proliferator-activated receptor alpha (PPARal
169 and protein, and this response is absent in peroxisome proliferator-activated receptor alpha (PPARal
170 ering fibrates that function as agonists for peroxisome proliferator-activated receptor alpha (PPARal
171 a, retinoid X receptor alpha (RXRalpha) plus peroxisome proliferator-activated receptor alpha (PPARal
172 A previous study identified the peroxisome proliferator-activated receptor alpha (PPARal
173 nd retinoid X receptor alpha (RXRalpha) plus peroxisome proliferator-activated receptor alpha (PPARal
174 The nuclear receptor peroxisome proliferator-activated receptor alpha (PPARal
175 Peroxisome proliferator-activated receptor alpha (PPARal
176 nd retinoid X receptor alpha (RXRalpha) plus peroxisome proliferator-activated receptor alpha (PPARal
177 some proliferators activate nuclear receptor peroxisome proliferator-activated receptor alpha (PPARal
178 ted the possible therapeutic activity of the peroxisome proliferator-activated receptor alpha (PPARal
179 Fas, and Srebp-1c was severely attenuated in peroxisome proliferator-activated receptor alpha (PPARal
180 such as bezafibrate, known activators of the peroxisome proliferator-activated receptor alpha (PPARal
181 the aryl hydrocarbon receptor (AHR) and the peroxisome proliferator-activated receptor alpha (PPARal
182 Genes directly interacting with peroxisome proliferator-activated receptor alpha (PPARal
183 Activation of peroxisome proliferator-activated receptor alpha (PPARal
184 HEA), a C19 human adrenal steroid, activates peroxisome proliferator-activated receptor alpha (PPARal
185 vation of the FA-activated nuclear receptor, peroxisome proliferator-activated receptor alpha (PPARal
186 Peroxisome proliferator-activated receptor alpha (PPARal
187 ific DRE that overlaps binding sequences for peroxisome proliferator-activated receptor alpha (PPARal
188 tocyte nuclear factor 4alpha (HNF4alpha) and peroxisome proliferator-activated receptor alpha (PPARal
189 yunsaturated fatty acids (PUFA) and WY14643 (peroxisome proliferator-activated receptor alpha (PPARal
190 Peroxisome proliferator-activated receptor alpha (PPARal
191 ibition of pro-beta-oxidative genes, such as peroxisome proliferator-activated receptor alpha (PPARal
192 creases in the expression of skeletal muscle peroxisome proliferator-activated receptor alpha (PPARal
193 Peroxisome proliferator-activated receptor alpha (PPARal
194 Peroxisome proliferator-activated receptor alpha (PPARal
195 ent (IC50 approximately 24 nM) and selective peroxisome proliferator-activated receptor alpha (PPARal
196 Peroxisome proliferator-activated receptor alpha (PPARal
197 by agonists of lipid-activated NR, including peroxisome proliferator-activated receptor alpha (PPARal
198 The nuclear receptor peroxisome proliferator-activated receptor alpha (PPARal
199 atoma FAO cells with Wy14,643, an agonist of peroxisome proliferator-activated receptor alpha (PPARal
200 unction as agonists for the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARal
201 tion was associated with an up-regulation of peroxisome proliferator-activated receptor alpha (PPARal
202 Proper function of the peroxisome proliferator-activated receptor alpha (PPARal
203 Expression of the nuclear hormone receptor peroxisome proliferator-activated receptor alpha (PPARal
204 The role of peroxisome proliferator-activated receptor alpha (PPARal
205 To explore the role of peroxisome proliferator-activated receptor alpha (PPARal
206 eroxisomal beta-oxidation system consists of peroxisome proliferator-activated receptor alpha (PPARal
207 Peroxisome proliferator-activated receptor alpha (PPARal
208 and mixed hyperlipidemia presumably through peroxisome proliferator-activated receptor alpha (PPARal
209 WY14,643 is a specific peroxisome proliferator-activated receptor alpha (PPARal
210 The peroxisome proliferator-activated receptor alpha (PPARal
211 ovel class of PPAs that act independently of peroxisome proliferator-activated receptor alpha (PPARal
212 Peroxisome proliferator-activated receptor alpha (PPARal
213 and the retinoid X alpha (RXRalpha) plus the peroxisome proliferator-activated receptor alpha (PPARal
214 t UCP-2 and UCP-3 expression, and 2) whether peroxisome proliferator-activated receptor alpha (PPARal
215 Peroxisome proliferators, which function as peroxisome proliferator-activated receptor alpha (PPARal
216 anscriptional level, is localized to an LCFA/peroxisome proliferator-activated receptor alpha (PPARal
217 anscriptional level via the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARal
218 rate switching in the hypertrophied heart is peroxisome proliferator-activated receptor alpha (PPARal
219 phosphorylates serine 73 (Ser(P)(73)) of the peroxisome proliferator-activated receptor alpha (PPARal
220 Because peroxisome proliferator-activated receptor alpha (PPARal
221 he interaction and synergy between CREBH and peroxisome proliferator-activated receptor alpha (PPARal
222 Peroxisome proliferator-activated receptor alpha (PPARal
223 higher activity of the androgen-induced gene peroxisome proliferator-activated receptor alpha (PPARal
224 tanoic acid (PFOA) increases mouse and human peroxisome proliferator-activated receptor alpha (PPARal
225 One of these NRs is peroxisome proliferator-activated receptor alpha (PPARal
226 id-lowering drug and a potent agonist of the peroxisome proliferator-activated receptor alpha (PPARal
227 gen species (ROS) activate ligand binding to peroxisome proliferator-activated receptor alpha (PPARal
228 In turn, peroxisome proliferator-activated receptor alpha (PPARal
229 genes in concert with reduced signaling via peroxisome proliferator-activated receptor alpha (PPARal
230 n unit was co-transcriptionally regulated by peroxisome proliferator-activated receptor alpha (PPARal
231 Western diet-fed wild type mice, but not in peroxisome proliferator-activated receptor alpha (PPARal
232 entified as a transcriptional of the protein peroxisome proliferator-activated receptor alpha (PPARal
233 Peroxisome proliferator-activated receptor alpha (PPARal
234 periostin resulted in reduced expression of peroxisome proliferator-activated receptor alpha (PPARal
235 Here we show that intestinal peroxisome proliferator-activated receptor alpha (PPARal
236 In this study the mechanism of peroxisome proliferator-activated receptor alpha (PPARal
237 Moreover, FAs activate peroxisome proliferator-activated receptor alpha (PPARal
238 Fenofibrate, a peroxisome proliferator-activated receptor alpha (PPARal
239 In addition, RXRalpha/peroxisome proliferator-activated receptor alpha (PPARal
240 We investigated conformational changes in peroxisome proliferator-activated receptor alpha (PPARal
241 mice display increased expression of hepatic peroxisome proliferator-activated receptor alpha (PPARal
242 ed that the C3 gene is the direct target for peroxisome proliferator-activated receptor alpha (PPARal
243 Hnf1a, as well as Nr3c1 (Gr), Nfe2l2 (Nrf2), peroxisome proliferator-activated receptor alpha (Pparal
244 al studies have reported that fenofibrate, a peroxisome proliferator-activated receptor alpha (PPARal
245 thway such as leukotriene B4 to activate the peroxisome proliferator-activated receptor alpha (PPARal
246 acyl-CoA synthetase 1 (ACSL1) is induced by peroxisome proliferator-activated receptor alpha (PPARal
247 eatment of fenofibrate (FB) 100 mg/kg/day, a peroxisome proliferator-activated receptor alpha (PPARal
248 1) gene expression in part by activating the peroxisome proliferator-activated receptor-alpha (PPARal
249 brozil and fenofibrate are known to activate peroxisome proliferator-activated receptor-alpha (PPARal
250 Here we investigated the role of peroxisome proliferator-activated receptor-alpha (PPARal
251 nd that CARHSP1 can physically interact with peroxisome proliferator-activated receptor-alpha (PPARal
252 zyme that function as biological ligands for peroxisome proliferator-activated receptor-alpha (PPARal
253 MPK), phosphatidylinositol 3 kinase-AKT, and peroxisome proliferator-activated receptor-alpha (PPARal
254 Peroxisome proliferator-activated receptor-alpha (PPARal
255 Peroxisome proliferator-activated receptor-alpha (PPARal
256 We show for the first time that the peroxisome proliferator-activated receptor-alpha (PPARal
257 The nuclear receptor, peroxisome proliferator-activated receptor-alpha (PPARal
258 The peroxisome proliferator-activated receptor-alpha (PPARal
259 Downregulation of peroxisome proliferator-activated receptor-alpha (PPARal
260 Because peroxisome proliferator-activated receptor-alpha (PPARal
261 The nuclear receptor (NR) peroxisome proliferator-activated receptor-alpha (PPARal
262 isome proliferator chemicals, acting via the peroxisome proliferator-activated receptor-alpha (Pparal
263 The nuclear receptors peroxisome proliferator-activated receptor-alpha (PPARal
264 ontroversy exists in determining the role of peroxisome proliferator-activated receptor-alpha (PPARal
265 The peroxisome proliferator-activated receptor-alpha (PPARal
266 and their coordinating transcription factor, peroxisome proliferator-activated receptor-alpha (PPARal
267 Peroxisome proliferator-activated receptor-alpha (PPARal
268 ing fatty acid beta-oxidation with GW7647, a peroxisome proliferator-activated receptor-alpha (PPARal
269 insulin and mTORC1 signaling was activated, peroxisome proliferator-activated receptor-alpha (PPARal
270 The nuclear receptors peroxisome proliferator-activated receptor-alpha (PPARal
271 Finally, the peroxisome-proliferator activated receptor alpha (PPARal
272 d increased UCP1protein expression; however, peroxisome-proliferator-activated-receptor-alpha (PPARal
273 consumption, mitochondrial mass, PPARalpha (peroxisome proliferator-activated receptor alpha) protei
274 gene is an AMP-activated protein kinase and peroxisome proliferator-activated receptor alpha respons
275 sis revealed a decrease in the expression of peroxisome proliferator-activated receptor alpha-respons
276 ndrostane receptor, pregnane X receptor, and peroxisome proliferator-activated receptor alpha results
277 oth L-FABP and MTP promoters are occupied by peroxisome proliferator-activated receptor alpha-retinoi
278 The combined findings indicate that peroxisome proliferator-activated receptor alpha-RXRalph
279 from the ligand-binding domain of the human peroxisome proliferator-activated receptor-alpha showed
280 also had showed disrupted signaling of Sirt1/peroxisome proliferator-activated receptor-alpha signali
281 acellular lipid storage dynamics to impaired peroxisome proliferator-activated receptor-alpha signali
282 ared with wild-type mice irrespective of the peroxisome proliferator-activated receptor-alpha status
283 specific polyunsaturated fatty acids control peroxisome proliferator activated receptor alpha, sterol
284 e major transcriptional regulatory networks: peroxisome proliferator-activated receptor alpha, sterol
285 rked changes in hepatic mRNA for C/EBPdelta, peroxisome proliferator-activated receptor alpha, sterol
286 factor 4 and retinoid X receptor alpha plus peroxisome proliferator-activated receptor alpha, suppor
287 Falpha (3.0-fold), whereas the expression of peroxisome proliferator-activated receptor alpha target
289 to a suppression of PGC-1alpha activation of peroxisome proliferator-activated receptor alpha target
290 was also shown to directly activate a known peroxisome proliferator-activated receptor alpha target,
292 the fasting-induced activation of PPARalpha (peroxisome proliferator activated receptor alpha), the m
293 regulate hypoxia-inducible factor-1alpha and peroxisome proliferator-activated receptor-alpha, thereb
294 ivated receptor gamma coactivator 1alpha and peroxisome proliferator-activated receptor alpha was red
295 ible factor-1alpha was downregulated whereas peroxisome proliferator-activated receptor-alpha was upr
298 ment binding protein-hepatocyte specific and peroxisome proliferator-activated receptor alpha, which
299 s), a family of endogenous lipid agonists of peroxisome proliferator-activated receptor-alpha, which
300 r-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha, which
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。